HF
TARO

HRT Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

HRT Financial’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,045
Closed -$294K – 3305
2023
Q4 		$294K Buy
+7,045
New +$260K ﹤0.01% 1633
2022
Q3 		– Sell
-14,586
Closed -$527K – 3688
2022
Q2 		$527K Buy
+14,586
New +$556K 0.01% 1436

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

HRT Financial's TARO Position: Q1 2024 in Review

HRT Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 7,045 shares — an estimated $294K sold.

HRT Financial first reported a position in TARO in Q2 2022 and held it in 2 quarters. The position peaked at $527K in Q2 2022. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • HRT Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 7,045 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $294K.
  • HRT Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2022 and held it in 2 quarters.
  • HRT Financial's Taro Pharmaceutical Industries Ltd. position peaked at $527K in Q2 2022.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.